The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Safety and efficacy of combining PD-L1 and CTLA-4 blockade with transarterial chemoembolization in intermediate-stage hepatocellular carcinoma: A phase II study.
 
Amy Kim
Consulting or Advisory Role - AstraZeneca
Research Funding - AstraZeneca
 
Mark Yarchoan
Leadership - Adventris
Stock and Other Ownership Interests - Adventris
Consulting or Advisory Role - AstraZeneca; Genentech/Roche; Hepion Pharmaceuticals; Rep Immune
Research Funding - Bristol-Myers Squibb; Exelixis; Incyte; Merck
 
Marina Baretti
Consulting or Advisory Role - AstraZeneca; Incyte
 
Paige Griffith
Honoraria - AstraZeneca
Speakers' Bureau - AstraZeneca
 
Won Jin Ho
Honoraria - NeoTX (Inst); Sanofi (Inst)
Consulting or Advisory Role - Exelixis
Patents, Royalties, Other Intellectual Property - Rodeo Therapeutics
 
Rose Parkinson
No Relationships to Disclose
 
Ewa Kulikowicz
No Relationships to Disclose
 
Yvette Cetasaan
No Relationships to Disclose
 
Brad Wilt
No Relationships to Disclose
 
Harry Luu
No Relationships to Disclose
 
Hao Wang
No Relationships to Disclose
 
Hyunsoo Song
No Relationships to Disclose
 
Robert Liddell
No Relationships to Disclose
 
Christos Georgiades
No Relationships to Disclose
 
Kelvin Hong
Consulting or Advisory Role - Boston Scientific; BTG; Varian Biopharma
Research Funding - BTG; Merit Medical Systems
 
Ana De Jesus Acosta
Consulting or Advisory Role - Merck
Research Funding - AstraZeneca (Inst); Merck (Inst)